Sequent Scientific Limited (NSE:SEQUENT)

Market Cap	43.47B
Revenue (ttm)	16.03B
Net Income (ttm)	296.78M
Shares Out	n/a
EPS (ttm)	1.15
PE Ratio	146.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	198,767
Average Volume	515,334
Open	173.80
Previous Close	174.83
Day's Range	172.00 - 175.00
52-Week Range	117.35 - 240.70
Beta	0.91
RSI	44.97
Earnings Date	Aug 8, 2025

About Sequent Scientific

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 1,244
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SEQUENT